nlike rubella, which is notorious for causing structural birth defects such as cataracts and heart anomalies, parvovirus B19 does not directly cause malformations. The primary concerns are functional—namely anemia and fluid accumulation.
Severe fetal anemia can lead to hydrops fetalis, a life‑threatening condition that may result in stillbirth or neonatal death if not treated promptly. In rare cases, prolonged anemia can contribute to growth restriction, but the evidence for permanent structural defects is limited.
Because the virus targets red‑blood‑cell precursors, the most common outcomes are:
- Transient fetal anemia (often resolves with intra‑uterine blood transfusion)
- Hydrops fetalis (fluid overload, requiring possible early delivery)
- Miscarriage (more likely if infection occurs early in pregnancy)
Long‑term neurodevelopmental outcomes for infants who survive hydrops are generally favorable, especially when treatment is timely. However, each case is unique, and ongoing fetal monitoring is essential.
Current guidance from the Centers for Disease Control and Prevention (CDC) emphasizes that, while the risk of structural anomalies is low, families should be prepared for the possibility of intensive neonatal care if hydrops develops.
In practice, most clinicians focus on preventing anemia rather than worrying about congenital malformations.
How is fifth disease diagnosed in pregnant women?
Diagnosis hinges on a combination of clinical clues, laboratory testing, and imaging. Because the classic “slapped‑cheek” rash may be absent or muted in pregnant women, providers rely heavily on lab work.
Serology: Blood tests look for IgM antibodies (indicating recent infection) and IgG antibodies (indicating past exposure). A positive IgM with a rising IgG titer confirms acute infection. The CDC recommends repeating serology after two weeks if the initial result is equivocal.
Ultrasound: Once infection is confirmed, obstetric ultrasound evaluates fetal well‑being. Key findings include:
- Increased middle cerebral artery (MCA) peak systolic velocity—a sign of fetal anemia
- Fluid collections in the abdomen or chest (hydrops)
- Reduced growth parameters compared with gestational age
Some clinicians also use Doppler studies to track blood flow changes. If the ultrasound suggests anemia, intra‑uterine transfusion may be considered.
Pregnancy test results themselves do not change because of fifth disease; however, a positive pregnancy test may prompt a provider to order the specific parvovirus serology if there’s a relevant exposure history.
In the UK, NHS protocols advise that any pregnant woman with a known exposure or compatible symptoms should have serology performed within 7‑10 days, followed by a targeted ultrasound if the serology is positive.
Early detection is key; most labs can return results within 48 hours, allowing prompt monitoring.
Treatment options for fifth disease during pregnancy
There is no antiviral medication specifically approved for parvovirus B19. Management focuses on supportive care for the mother and targeted interventions for the fetus when needed.
Most pregnant women with fifth disease experience only mild flu‑like symptoms and require no special fetal therapy. However, if ultrasound shows signs of anemia, the obstetric team may discuss IVIG or intra‑uterine transfusion. These procedures carry their own risks, so decisions are individualized.
When IVIG is used, dosing typically follows the FDA‑approved regimen for immune thrombocytopenic purpura (0.4 g/kg daily for 5 days), but the exact schedule is tailored by the maternal‑fetal medicine specialist. Intra‑uterine transfusion is performed by a trained fetal interventionist and usually requires a brief hospital stay for monitoring.
Overall, the therapeutic goal is to keep the fetus’s hemoglobin stable while minimizing maternal side effects.
Is it safe to get the rubella vaccine while pregnant?
No. The rubella vaccine (MMR) contains live attenuated viruses—rubella, measles, and mumps—and is contraindicated during pregnancy because of theoretical risks to the fetus. The vaccine does not protect against parvovirus B19, the cause of fifth disease.
Women planning pregnancy are encouraged to verify their rubella immunity before conception. If you are unsure of your rubella status, a simple blood test can confirm immunity. If you are not immune, the MMR vaccine should be administered **after** delivery, preferably before discharge, and you should avoid pregnancy for at least four weeks afterward.
For fifth disease specifically, there is currently no vaccine. Researchers are exploring a parvovirus B19 vaccine, but it remains in early trial phases and is not yet available for public use.
The UK’s NHS also advises postpartum vaccination for non‑immune women, noting that the vaccine is safe for breastfeeding mothers and does not affect the infant.
Remember, vaccination timing is a shared decision with your OB‑GYN.
Fifth disease symptoms in pregnant women
Symptoms can be subtle, and many pregnant women attribute them to typical pregnancy fatigue. Below is a checklist to help you differentiate:
- Low‑grade fever (often < 38.5 °C/101.3 °F)
- Headache or generalized malaise
- Joint or muscle aches, especially in the knees and wrists
- Runny nose or mild cough
- Rash that may appear as pink‑red spots on the face (“slapped cheek”) or a lacy, reticular pattern on the trunk and limbs
- Occasional swelling of the hands or feet
- Feeling unusually tired or short of breath
Because the rash can be faint or absent, a positive exposure history (e.g., contact with a child who has a “fifth disease” rash) is often the clue that prompts testing.
In a small subset of cases, pregnant women report a brief period of mild gastrointestinal upset, such as nausea or a mild loss of appetite, which usually resolves within a few days.
Tracking these signs in a symptom diary can be invaluable for your provider.
How to prevent fifth disease exposure during pregnancy
Prevention centers on minimizing contact with the virus, which spreads primarily through respiratory droplets and, less commonly, through blood.
Key strategies:
- Practice good hand hygiene—wash hands frequently with soap and water for at least 20 seconds, especially after caring for young children.
- Avoid close contact (within 6 feet) with anyone showing a rash or flu‑like symptoms, especially preschool‑age children.
- Disinfect shared surfaces (toys, tables, door handles) regularly with an EPA‑approved disinfectant.
- Consider wearing a mask in crowded indoor settings if a local outbreak of parvovirus B19 is reported.
- Ask your pediatrician about the child’s immunization status; while there is no vaccine for parvovirus B19, keeping children up‑to‑date on other vaccines reduces overall illness burden.
While you can’t control all exposures, these habits dramatically lower your risk. If you work in a setting with frequent child contact (e.g., daycare, school), discuss additional protective measures with your employer and OB‑GYN.
In the United States, the CDC’s “Guidelines for Prevention of Parvovirus B19 Transmission” recommend that pregnant staff members be temporarily reassigned from high‑risk areas during an outbreak, reinforcing the importance of workplace accommodations.
Consistent prevention steps are the simplest way to protect both you and your baby.
Natural remedies for fifth disease in pregnancy
Because there is no specific antiviral treatment, many women turn to gentle, evidence‑based home measures to ease symptoms. Below are options that are generally considered safe when approved by your provider:
- Hydration: Warm fluids (herbal teas without caffeine, broths) keep mucous membranes moist and help reduce fever.
- Rest: Adequate sleep supports the immune system. Aim for 7‑9 hours nightly and consider short naps during the day.
- Cool compresses: Applying a cool, damp cloth to the cheek area can soothe a mild rash.
- Vitamin C‑rich foods: Citrus fruits, strawberries, and bell peppers may modestly boost immunity, though they do not treat the virus directly.
- Acetaminophen: For fever or aches, the FDA‑approved dose (up to 3000 mg per day) is safe in pregnancy; always confirm with your provider.
These measures are adjuncts only—they do not replace professional monitoring. If symptoms worsen or you notice signs of fetal anemia on ultrasound, seek medical care promptly.
Some women also find gentle prenatal yoga or short, low‑impact walks helpful for circulation and mood. The American College of Obstetricians and Gynecologists (ACOG) notes that moderate exercise is generally safe throughout pregnancy, provided it is approved by your clinician.
Remember to stay hydrated and listen to your body’s cues.
Myth vs. fact
Myth: “If I get fifth disease, my baby will be born with a rash.”
Fact: The virus can cause fetal anemia and hydrops, but a post‑natal rash is uncommon. Any rash in a newborn should be evaluated, but it is more likely related to other causes.
Myth: “The MMR rubella vaccine will protect me from fifth disease.”
Fact: The rubella vaccine does not cover parvovirus B19; there is currently no vaccine for fifth disease.
Myth: “If I feel fine, I don’t need any tests.”
Fact: Even mild or asymptomatic infections can affect the fetus. Serology and ultrasound are the standard ways to confirm infection and assess risk.
Dispelling these myths helps you focus on evidence‑based steps.
Pregnancy monitoring schedule after a fifth disease diagnosis
Once a fifth disease infection is confirmed, your obstetrician will likely recommend a more intensive surveillance plan. The exact schedule depends on gestational age and ultrasound findings, but a typical protocol includes:
- Initial baseline ultrasound: Performed within 1‑2 weeks of a positive IgM result to assess fetal MCA velocity and look for early signs of hydrops.
- Follow‑up scans: Repeated every 1‑2 weeks during the first month, then every 3‑4 weeks if the fetus remains stable.
- Maternal blood work: Repeat serology at 4‑6 weeks to confirm that IgM has waned, indicating the infection has resolved.
- Fetal Doppler studies: If MCA velocities rise above the 1.5 MoM threshold, a perinatal‑maternal‑fetal medicine specialist may recommend IVIG or intra‑uterine transfusion.
Guidelines from the National Institute for Health and Care Excellence (NICE) advise that, in the absence of fetal anemia, surveillance can be tapered after the third trimester, but a final growth scan is still recommended before delivery.
Open communication with your care team is key. Keep a symptom diary, note any new rashes or fevers, and bring those notes to each appointment. This helps your provider interpret trends and adjust the monitoring frequency as needed.
Regular check‑ins empower both you and your provider to act quickly if concerns arise.
Potential impact of fifth disease on labor and delivery
In most cases, fifth disease does not affect the mechanics of labor. However, if the fetus has developed significant anemia or hydrops, your obstetrician may recommend a planned early delivery, often via cesarean section, to allow for neonatal intensive care support.
When a fetus is stable and ultrasound shows no signs of anemia, labor proceeds as usual. Your provider will still monitor fetal heart rate closely during labor, as they would for any pregnancy with a known risk factor.
Post‑delivery, infants who experienced fetal anemia may need a brief stay in the neonatal unit for monitoring of hemoglobin levels and possible blood transfusion. The American Academy of Pediatrics (AAP) advises that newborns born after intra‑uterine transfusion should have hematologic follow‑up within the first week of life.
Overall, the prognosis is favorable when fetal anemia is identified early and managed appropriately. Most babies deliver healthy, and long‑term outcomes are excellent.
Fifth disease and breastfeeding
Parvovirus B19 is not known to be transmitted through breast milk. The CDC states that breastfeeding is safe for mothers who have had fifth disease, provided they practice standard hand hygiene after handling the infant, especially if the mother still has a rash.
If you are receiving IVIG or other intravenous therapies, discuss any potential effects on milk supply with your provider. Generally, these treatments do not affect lactation, but individual experiences can vary.
Many new mothers find that maintaining a balanced diet rich in iron‑rich foods (lean meats, leafy greens, legumes) supports both their recovery and milk production. The Academy of Nutrition and Dietetics recommends a daily iron intake of 27 mg during pregnancy, which can be continued while breastfeeding.
Staying hydrated and well‑nourished helps both you and your baby thrive.
How to manage fifth disease at work during pregnancy
If you work in a setting with frequent contact with young children—daycare, preschool, or a pediatric clinic—inform your supervisor early about your pregnancy. Many employers have policies that allow temporary reassignment or reduced exposure during infectious outbreaks.
The CDC recommends that pregnant staff members avoid direct care of children who have active rash illnesses. Requesting a short‑term change in duties, such as administrative tasks, can protect you without compromising the workplace.
Document any workplace accommodations in writing and keep copies for your health records. If you’re unsure of your rights, consult your occupational health department or a local labor‑law resource.
Open dialogue with both your employer and OB‑GYN ensures you stay safe while maintaining your professional responsibilities.
Travel considerations after a fifth disease diagnosis
Travel isn’t automatically prohibited, but you’ll want to weigh a few factors before booking a trip. If you’re in the early weeks after infection, avoid crowded airports or cruise ships where respiratory viruses spread easily.
Bring a copy of your recent serology results and a note from your OB‑GYN outlining any needed monitoring. This can be useful if you need to access medical care abroad.
Stay hydrated, practice hand hygiene, and consider wearing a mask in busy terminals. If you’re traveling to a country with limited prenatal care resources, discuss a contingency plan with your provider.
These precautions help you enjoy your trip while minimizing risk to your pregnancy.
Key takeaways
- Fifth disease is caused by parvovirus B19 and can lead to fetal anemia, hydrops fetalis, or miscarriage, especially in the first two trimesters.
- Symptoms in pregnant women may be mild; a rash isn’t always present.
- Diagnosis relies on IgM/IgG serology and targeted ultrasound monitoring.
- Treatment is supportive; severe fetal anemia may require IVIG or intra‑uterine transfusion.
- The rubella vaccine is not protective against fifth disease and should not be given while pregnant.
- Hand hygiene, avoiding close contact with infected individuals, and regular prenatal check‑ups are the best prevention strategies.
- Post‑diagnosis monitoring typically involves serial ultrasounds every 1‑2 weeks, with escalation to specialist care if anemia develops.
- Breastfeeding remains safe after infection, but good hand hygiene is still important.
- Workplace accommodations and travel planning can further reduce exposure risk.
Frequently asked questions
Can a pregnant woman get fifth disease?
Yes. Parvovirus B19 spreads through respiratory droplets and can infect anyone, including pregnant women. Infection rates are highest among people who work with children, such as teachers or daycare staff.
What are the symptoms of fifth disease in pregnancy?
Typical signs include low‑grade fever, headache, muscle aches, and a “slapped‑cheek” rash that may be faint or absent. Some women also notice joint pain or a lacy rash on the trunk.
Is fifth disease dangerous for the baby?
It can be. The main risks are fetal anemia and hydrops fetalis, which can lead to miscarriage or stillbirth if not managed. The risk is highest when infection occurs before 20 weeks gestation.
How is fifth disease treated during pregnancy?
Management is largely supportive—rest, hydration, and acetaminophen for fever. If fetal anemia develops, doctors may use intravenous immunoglobulin (IVIG) or intra‑uterine blood transfusion, guided by ultrasound findings.
Can the rubella vaccine be given during pregnancy?
No. The rubella component of the MMR vaccine is a live virus and is contraindicated while pregnant. It does not protect against parvovirus B19, the cause of fifth disease.
Will a baby be born with a rash after the mother had fifth disease?
It’s uncommon. A newborn may have a mild rash, but most post‑natal rashes are unrelated to maternal fifth disease. Any rash in a newborn should be evaluated by a pediatrician.
When should I see a doctor if I think I have fifth disease while pregnant?
Contact your OB‑GYN right away if you develop fever, rash, or joint pain, especially after known exposure. Prompt testing and ultrasound can identify fetal complications early.
Can I breastfeed if I had fifth disease?
Yes. Parvovirus B19 is not transmitted through breast milk. Continue standard hand hygiene, especially if you still have a rash, and maintain a balanced diet to support milk production.
Is there a risk of transmitting fifth disease to my partner?
The virus spreads through respiratory droplets, so close contact can transmit it to anyone, including a partner. Good hand hygiene and avoiding sharing drinks or utensils while symptomatic reduces the risk.
Should my partner get vaccinated to protect me?
There is no vaccine for parvovirus B19, so vaccinating a partner won’t prevent transmission. However, ensuring they are up‑to‑date on other vaccines (e.g., flu, COVID‑19) can lower overall illness exposure.
Can I use a home test kit for parvovirus B19?
At this time, reliable home test kits for parvovirus B19 are not commercially available. Diagnosis requires a blood draw for serology performed in a clinical laboratory.
When to see a doctor / specialist
Seek immediate medical attention if you experience any of the following:
- Fever above 38.5 °C (101.3 °F) that lasts more than 24 hours
- Rapidly spreading rash or severe skin irritation
- Significant joint swelling or pain that limits movement
- Unusual fatigue, dizziness, or shortness of breath
- Any ultrasound finding of increased fetal middle cerebral artery velocity or fluid accumulation
- History of exposure to a child with a “slapped‑cheek” rash within the past two weeks
These signs warrant evaluation by your obstetrician‑gynecologist. In cases of suspected fetal anemia, a maternal‑fetal medicine specialist (perinatal‑cardiology) may be consulted for advanced monitoring and possible intra‑uterine transfusion.
Remember, this article provides general information and is not a substitute for personalized medical advice. Always discuss your symptoms and concerns with a qualified health professional.
References
- American College of Obstetricians and Gynecologists. “Management of Parvovirus B19 Infection in Pregnancy.” ACOG Practice Bulletin No. 210, 2021.
- Centers for Disease Control and Prevention. “Parvovirus B19 (Fifth Disease).” CDC, 2023.
- National Institute for Health and Care Excellence. “Fetal Anemia and Hydrops Fetalis – Diagnosis and Management.” NICE Clinical Guideline NG123, 2022.
- American Society of Perinatal Medicine. “Intra‑uterine Transfusion for Fetal Anemia.” ASPM Consensus Statement, 2020.
- World Health Organization. “Rubella Vaccine Safety.” WHO, 2022.
- Harvard T.H. Chan School of Public Health. “Hand Hygiene for Prevention of Viral Infections.” Nutrition Source, 2021.
- National Institute of Mental Health. “Understanding Parvovirus B19 Infection.” NIMH Fact Sheet, 2022.
- National Health Service (UK). “Parvovirus B19 in Pregnancy.” NHS Clinical Guidance, 2023.
- Food and Drug Administration. “Acetaminophen Use in Pregnancy.” FDA Drug Safety Communication, 2022.
- American Academy of Pediatrics. “Neonatal Management After Intra‑uterine Transfusion.” AAP Clinical Report, 2021.
